FibroScan®

FibroScan®: Painless, Accurate, Noninvasive Way to Assess Liver Health The Illinois Center For Digestive and Liver Health, a leader in healthcare management, now offers FibroScan® to assess liver health and support early detection and management of liver disease. Liver disease, such as nonalcoholic fatty liver disease (NAFLD), is associated with obesity, insulin resistance, diabetes and other metabolic risk factors. One in three Americans have liver disease.

Maintaining good liver health is important to your overall health. That's why physicians at the Illinois Center For Digestive and Liver Health use FDA-approved FibroScan®:

• Quick: takes just 10-minutes

• Noninvasive and painless

FibroScan: How it works:

• The patients lie comfortably on an exam table

• The medical professional applies a water-based gel

• on the patient's skin and places the Fibroscan®

• probe on the right side of the ribcage

• The medical professional then takes 10 quick, painless measurements

• Results are immediate for the physician to interpret

Benefits of FibroScan:

• Non-Invasive assessment of liver steatosis and fibrosis and an aid to the diagnosis and monitoring of liver health.

• Highly cost effective diagnostic platform for point of care indication of advanced fibrosis or cirrhosis

• Covered under commercial, Medicare and Medicaid

• Efficient diagnostic to stimulate and refine referral pathways

• Mitigates the need for invasive or expensive testing and biopsies

• Helps to more efficiently identify and monitor patients who are suitable for clinical trials, drug prescriptions and emerging therapies